Phase I study of cytokine-gene modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma.

Suppr

超能文献

出版信息

Hum Gene Ther. 1992 Dec;3(6):665-76. doi: 10.1089/hum.1992.3.6-665.

DOI:10.1089/hum.1992.3.6-665

PMID:1482707

Abstract

摘要

相似文献

Phase I study of cytokine-gene modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma.

Hum Gene Ther. 1992 Dec;3(6):665-76. doi: 10.1089/hum.1992.3.6-665.

A pilot study of immunization with HLA-A2 matched allogeneic melanoma cells that secrete interleukin-2 in patients with metastatic melanoma.一项针对转移性黑色素瘤患者，使用分泌白细胞介素-2的HLA-A2匹配的同种异体黑色素瘤细胞进行免疫治疗的初步研究。

Hum Gene Ther. 1992 Dec;3(6):677-90. doi: 10.1089/hum.1992.3.6-677.

A pilot study of immunization with interleukin-2 secreting allogeneic HLA-A2 matched renal cell carcinoma cells in patients with advanced renal cell carcinoma.一项针对晚期肾细胞癌患者，采用分泌白细胞介素-2的异体人白细胞抗原A2匹配肾癌细胞进行免疫治疗的初步研究。

Hum Gene Ther. 1992 Dec;3(6):691-703. doi: 10.1089/hum.1992.3.6-691.

Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma.在晚期或难治性神经母细胞瘤患者中，将转基因人淋巴细胞趋化因子与白细胞介素-2联合使用的同种异体肿瘤细胞疫苗的局部和全身效应。

Blood. 2003 Mar 1;101(5):1718-26. doi: 10.1182/blood-2002-08-2493. Epub 2002 Oct 24.

Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector.使用腺病毒载体进行趋化因子和细胞因子基因修饰的自体神经母细胞瘤细胞治疗复发/难治性神经母细胞瘤的I期研究。

Hum Gene Ther. 2000 Jul 1;11(10):1477-88. doi: 10.1089/10430340050057549.

Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma.白细胞介素-2基因修饰的同种异体肿瘤细胞用于治疗复发性神经母细胞瘤。

Hum Gene Ther. 1998 Jun 10;9(9):1303-11. doi: 10.1089/hum.1998.9.9-1303.

Interleukin-2 gene therapy in a patient with glioblastoma.

Gene Ther. 1995 Mar;2(2):164-7.

Assessment of the efficacy of purging by using gene marked autologous marrow transplantation for children with AML in first complete remission.采用基因标记自体骨髓移植对首次完全缓解的急性髓系白血病患儿进行清髓疗效评估。

Hum Gene Ther. 1994 Apr;5(4):481-99. doi: 10.1089/hum.1994.5.4-481.

Local IL-4 delivery enhances immune reactivity to murine tumors: gene therapy in combination with IL-2.

Cancer Gene Ther. 1994 Mar;1(1):35-42.

Administration of high-dose recombinant interleukin 2 after autologous bone marrow transplantation in patients with neuroblastoma: toxicity, efficacy and survival. A Lyon-Marseille-Curie-east of France Group Study.神经母细胞瘤患者自体骨髓移植后大剂量重组白细胞介素-2的应用：毒性、疗效和生存率。法国东部里昂-马赛-居里集团研究。

Prog Clin Biol Res. 1994;385:293-300.

引用本文的文献

Gene therapy in surgery: Part II: Application to septic shock and to organ transplantation.外科手术中的基因治疗：第二部分：在感染性休克和器官移植中的应用。

Acta Chir Austriaca. 1997;29(1):22-26. doi: 10.1007/BF02620270.

Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma.腺病毒介导的单纯疱疹病毒胸苷激酶给药可改善复发性高级别胶质瘤的治疗效果。

Oncotarget. 2016 Jan 26;7(4):4369-78. doi: 10.18632/oncotarget.6737.

A short perspective on gene therapy: Clinical experience on gene therapy of gliomablastoma multiforme.基因治疗的简短展望：多形性胶质母细胞瘤基因治疗的临床经验

World J Exp Med. 2011 Dec 20;1(1):10-6. doi: 10.5493/wjem.v1.i1.10.

Viral vectors for gene transfer: a review of their use in the treatment of human diseases.用于基因转移的病毒载体：其在人类疾病治疗中的应用综述

Drugs. 2000 Aug;60(2):249-71. doi: 10.2165/00003495-200060020-00002.

Gene therapy in pediatric oncology.儿童肿瘤学中的基因治疗。

Invest New Drugs. 1996;14(1):87-99. doi: 10.1007/BF00173685.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验